"Atrium Health Levine Cancer Institute, a facility of Atrium Health Lincoln provides access to top-ranked physician expertise, groundbreaking clinical trials and the latest cancer treatments across the Carolinas."

During the past decade, Atrium Health Lincoln/LCI-Lincolnton conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Atrium Health Lincoln/LCI-Lincolnton" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator and "Canadian Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Atrium Health Lincoln/LCI-Lincolnton" are "Colon Adenocarcinoma" (3 trials), "Extensive Stage Lung Small Cell Carcinoma" (2 trials), "Anal Basaloid Carcinoma" (1 trials), "Anal Canal Cloacogenic Carcinoma" (1 trials) and "Anal Margin Squamous Cell Carcinoma" (1 trials). Many other conditions were trialed in "Atrium Health Lincoln/LCI-Lincolnton" in a lesser frequency.

Most popular intervention types in "Atrium Health Lincoln/LCI-Lincolnton" are "Drug" (10 trials), "Procedure" (8 trials), "Other" (7 trials), "Biological" (6 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Computed Tomography" (7 trials), "Magnetic Resonance Imaging" (7 trials), "Biospecimen Collection" (6 trials), "Atezolizumab" (4 trials) and "Biopsy" (3 trials). Other intervention names were less common.

The vast majority of trials in "Atrium Health Lincoln/LCI-Lincolnton" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Atrium Health Lincoln/LCI-Lincolnton". undefined are not yet recruiting, 5 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Atrium Health Lincoln/LCI-Lincolnton, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Atrium Health Lincoln/LCI-Lincolnton, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".